TY - JOUR AU - Warrender-Sparkes, Matthew AU - Spelman, Tim AU - Izquierdo, Guillermo AU - Trojano, Maria AU - Lugaresi, Alessandra AU - Grand'Maison, François AU - Havrdova, Eva AU - Horakova, Dana AU - Boz, Cavit AU - Oreja-Guevara, Celia AU - Alroughani, Raed AU - Iuliano, Gerardo AU - Duquette, Pierre AU - Girard, Marc AU - Terzi, Murat AU - Hupperts, Raymond AU - Grammond, Pierre AU - Petersen, Thor AU - Fernandez-Bolaños, Ricardo AU - Fiol, Marcela AU - Pucci, Eugenio AU - Lechner-Scott, Jeannette AU - Verheul, Freek AU - Cristiano, Edgardo AU - Van Pesch, Vincent AU - Petkovska-Boskova, Tatjana AU - Moore, Fraser AU - Kister, Ilya AU - Bergamaschi, Roberto AU - Saladino, Maria Laura AU - Slee, Mark AU - Barnett, Michael AU - Amato, Maria Pia AU - Shaw, Cameron AU - Shuey, Neil AU - Young, Carolyn AU - Gray, Orla AU - Kappos, Ludwig AU - Butzkueven, Helmut AU - Kalincik, Tomas AU - Jokubaitis, Vilija AU - MSBase study group PY - 2015 DO - 10.1177/1352458515594041 UR - http://hdl.handle.net/10668/10005 T2 - Multiple sclerosis (Houndmills, Basingstoke, England) AB - We aimed to analyse the effect of the introduction of fingolimod, the first oral disease-modifying therapy, on treatment utilisation and persistence in an international cohort of patients with multiple sclerosis (MS). MSBASIS, a prospective,... LA - en KW - MSBase KW - Multiple sclerosis KW - disease-modifying therapy KW - fingolimod KW - medication persistence KW - Administration, Oral KW - Adult KW - Aged KW - Demyelinating Diseases KW - Drug Substitution KW - Female KW - Fingolimod Hydrochloride KW - Humans KW - Immunosuppressive Agents KW - Kaplan-Meier Estimate KW - Male KW - Medication Adherence KW - Middle Aged KW - Multiple Sclerosis, Relapsing-Remitting KW - Multivariate Analysis KW - Proportional Hazards Models KW - Prospective Studies KW - Registries KW - Risk Factors KW - Time Factors KW - Treatment Outcome TI - The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. TY - research article VL - 22 ER -